ArticleBMC public health2026
Cancer in migrant populations: evidence from a regional oncology network.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer care for vulnerable populations such as migrants remains poorly investigated. The Campania Oncology Network (Rete Oncologica Campana, ROC) was established in Campania, a region of southern Italy, to ensure equitable access to cancer care. This study aimed to assess the proportion and distribution of cancers among migrants within the ROC.Data were extracted from the ROC digital platform for all cancer cases diagnosed between 2022 and 2025. Adjusted proportionate morbidity ratios (PMRs) were calculated to compare the most common cancer types between migrants and non-migrants.Among 78,119 adult cancer patients, 2,583 (3.3%) were migrants. Migrants were younger than Italian patients, predominantly female, and largely originated from Europe. Migrant women showed higher proportions of cervical (PMR = 2.91; 95% CI: 2.38–3.54), ovarian (PMR = 1.46; 95% CI: 1.19–1.77), and endometrial cancer (PMR = 1.22; 95% CI: 1.01–1.48). Male migrants had increased proportions of stomach cancer (PMR = 1.37; 95% CI: 1.04–1.77) and hepatocellular carcinoma (PMR = 1.45; 95% CI: 1.12–1.85). Overall, migrants also showed modestly higher proportions of colon (PMR = 1.18; 95% CI: 1.03–1.35) and central nervous system cancers (PMR = 1.57; 95% CI: 1.20–2.03).Migrants within the ROC display distinct cancer patterns with marked gender differences. Higher proportions of gynecological cancers suggest gaps in access to HPV vaccination and screening, while increased stomach and liver cancers in men may reflect differing exposures. These findings underscore the need for gender-sensitive and culturally tailored strategies to improve cancer prevention, and equitable oncologic care for migrant populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.